Catalog No.
PVV40401
Species reactivity
Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant EBV/HHV-4 BZLF1 (Leu175-Phe245).
Target
Lytic switch protein BZLF1, EB1, Protein Z, Trans-activator protein BZLF1, Zta, bZIP transcription factor ZEBRA, BZLF1
Purification
Purified by antigen affinity column.
Accession
P03206
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Inhibitory effect of recombinant BCG containing the fusion gene BFNA on EB virus-positive tumors., PMID:40459582
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis., PMID:39742283
Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+KIR+CD56dim subsets., PMID:39676862
TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice., PMID:39387189
Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma., PMID:38894502
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma., PMID:38276183
Upregulation of IQGAP2 by EBV transactivator Rta and its influence on EBV life cycle., PMID:37504571
Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus., PMID:36782252
Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection., PMID:36007460
Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma., PMID:35633182
Association between HLA alleles and Epstein-Barr virus Zta-IgA serological status in healthy males from southern China., PMID:34164868
A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma., PMID:32780356
The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma., PMID:31619404
Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma., PMID:31618442
Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders., PMID:30998212
Molecular mimicry, genetic homology, and gene sharing proteomic "molecular fingerprints" using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease., PMID:30552620
Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia., PMID:29948559
The Role of Transforming Growth Factor β in Cell-to-Cell Contact-Mediated Epstein-Barr Virus Transmission., PMID:29867885
Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan., PMID:29301829
Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes., PMID:28228322
BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha., PMID:27334596
Molecular Approach to Targeted Therapy for Multiple Sclerosis., PMID:26560895
Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication., PMID:26537683
Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients., PMID:26526510
Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells., PMID:26431332
Production of thyrotropin receptor antibodies in acute phase of infectious mononucleosis due to Epstein-Barr virus primary infection: a case report of a child., PMID:26322262
Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation., PMID:26307954
Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum., PMID:25651045
Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites., PMID:25234411
Survey of Epstein Barr virus (EBV) immunogenic proteins and their epitopes: implications for vaccine preparation., PMID:25164057
Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1., PMID:25078688
Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies., PMID:24831943
Serum Zta antibody of Epstein-Barr virus exerts potential function in the diagnosis of nasopharyngeal cancer., PMID:24737587
Construction of a recombinant-BCG containing the LMP2A and BZLF1 genes and its significance in the Epstein-Barr virus positive gastric carcinoma., PMID:24699993
Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome., PMID:24454857
HLA peptide length preferences control CD8+ T cell responses., PMID:23749632
Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis., PMID:23592979
Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle., PMID:23592216
The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli., PMID:23015717
An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation., PMID:22972969
An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model., PMID:22623780
Performance of an immunofiltration assay detecting IgM antibodies against ZEBRA and viral capsid p18 proteins (Immunoquick(®) filtration EBV M) for the diagnosis of heterophile antibody-negative primary Epstein-Barr virus infection in children., PMID:22209289
Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus., PMID:21905083
Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene., PMID:21593157
Enhancement of Zta-activated lytic transcription of Epstein-Barr virus by Ku80., PMID:21123545
Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line., PMID:20861250
Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: joint effect with vitamin D?, PMID:20691583
Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humans., PMID:20419811
Construction and expression of a spliced variant of Epstein-Barr virus bzlf1 and preparation of its polyclonal antibody., PMID:20024794
[Research advancement on relationship between Epstein-Barr virus and breast cancer]., PMID:19664328
For research use only. Not for human or drug use.
